Contribute Try STAT+ Today
Trending:
Coronavirus
Health
Biotech
First Opinion
Trending
Eli Lilly headquarters
Eli Lilly says its monoclonal antibody prevented Covid-19 infections…
Eli Lilly says its monoclonal antibody prevented Covid-19 infections in clinical trial
newborn baby in hospital
Covid-19 vaccine guidance for those who are lactating is…
Covid-19 vaccine guidance for those who are lactating is based on faulty assumptions, experts say
A tale of two ampoules
A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines
A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines
Recommended
Amazon logo
‘What was left for Haven?’: How Amazon’s health ambitions…
‘What was left for Haven?’: How Amazon’s health ambitions devoured Haven’s plans
Virtual Event: A look ahead at biotech in 2021
Virtual Event: A look ahead at biotech in 2021
pig farm
FDA approves genetically altering pigs, to potentially make food,…
FDA approves genetically altering pigs, to potentially make food, drugs, and transplants safer

More in Business

In the Lab

It beats like the real thing, but can a miniature human heart prevent the next Vioxx?

By Sharon Begley

Amazon logo

‘What was left for Haven?’: How Amazon’s health ambitions devoured Haven’s plans

By Casey Ross and Erin Brodwin

Jennifer Schneider Health Tech Summit
Health Tech

As health tech flourished, Teladoc and Livongo saw an opportunity to ‘accelerate,’ executives say

By Elizabeth Cooney

Gilead White House photo illo
Special Report

With remdesivir, Gilead finds itself at strategic crossroads, with its reputation (and far more) at stake

By Nicholas Florko and Damian Garde

Atul Haven photo illustration
Special Report

Two years of halting progress and high turnover preceded Atul Gawande’s exit as Haven CEO

By Erin Brodwin and Casey Ross